Background:
. Stress factors lead to a shift in the antioxidant - prooxidant relationship towards an increase in the generation of reactive oxygen species (ROS) by mitochondria, which results in the development of oxidative stress. Consequently, it was possible to put forward assumption, that drugs that reduce the excessive generation of ROS by these organelles should increase the body's resistance to stress factors. Antioxidants can be used as such drugs. In this regard, the aim of this work was to study the bioenergetics characteristic of mitochondria under stress conditions and under the action of 2-ethyl-6-methyl-3-hydroxypyridinium hydroxybutanedioate (Ethoxidol)..
Methods:
The antiradical activity of the drug was evaluated by the chemiluminescent method (CL). Lipid peroxidation of mitochondrial membranes was studied by the fluorescent method. Changes in the composition of fatty acids in mitochondrial membranes were assessed by chromatography technique. The study of mitochondrial morphology was performed through the method of atomic force microscopy.
Results:
The injection in mice of Ethoxidol at a dose of 7 × 10-5mol / kg for 7 days inhibited the stress-induced increase in the intensity of LPO in the membranes of the mitochondria, prevented a decrease in the content of unsaturated C18 and C20 fatty acids and the swelling of these organelles under stress conditions. At the same time, Ethoxidol increased the life expectancy of mice by 3.0-4.2 times in conditions of various types of hypoxia.
Conclusion:
Supposedly, the adaptogenic properties of Ethoxidol are conditioned by its antiradical properties and its ability to inhibit LPO